Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Electromedical Technologies, Inc. (EMED)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Medical - Devices
Address
16561 North 92nd Street 85260
Scottsdale, AZ, US
Scottsdale, AZ, US
CEO
Matthew N. Wolfson
Website
electromedtech.com
IPO
2021-01-08
CIK 1715819 ISIN US28540Q1004
Description
Electromedical Technologies, Inc. operates within the U.S. market, specializing in the creation and distribution of bioelectronic medical devices specifically designed for pain management. The company's primary product is WellnessPro Plus, a prescription-based bioelectronic therapy tool utilized by both individual users and healthcare professionals to mitigate various forms of discomfort, including both persistent (chronic) and sudden (acute) pain. Established in 2002, the firm is headquartered in Scottsdale, Arizona.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
10M
Beta
1.10
Float Shares
802.10M
Free Float %
93.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +33.33% | +33.33% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -83.33% | -99.74% | -99.93% | -99.93% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-75.05
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-93.0% Q1'26: -73.5% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+125.0% ★ Q1'26: +150.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-325.5% Q1'26: -8,243.4% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-2,468.7% Q1'26: -5,982.2% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%— Q1'26: +32.4% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+351.2% Q1'26: +104.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-1.35× Q1'26: -1.32× (vs Q1'25)
Valuation Multiples
From
To
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-10 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-09 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-03 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-02 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-506.0K
OE per share TTM
0.00
Owner's Yield
-86.45%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
65.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
1
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dianna Kaplan | 3.83M | 7.50% | 3.83M | — | 3.83M | — | IN | US | 2021-09-21 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
35.00M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+35,000,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-06 | Hymers III R. Leslie | Director | A-Award | A | Common Stock | 35,000,000 | 0.01 | 297.5K | 35,049,295 | — | ↗ |
| 2022-12-20 | Hymers III R. Leslie | Director | — | D | Common Stock | 0 | 0.00 | — | 49,295 | — | ↗ |
| 2022-11-02 | Benson Lee | Director | A-Award | A | Common Stock | 1,658,999 | 0.01 | 20.7K | 1,658,999 | — | ↗ |
| 2022-09-29 | Benson Lee | Director | — | I | Common | 0 | 0.00 | — | 6,800,000 | — | ↗ |
| 2021-07-08 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common | 57,417 | 0.07 | 3.8K | 3,338,249 | — | ↗ |
| 2021-07-01 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 40,000 | 0.08 | 3.1K | 3,395,666 | — | ↗ |
| 2021-06-10 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 22,500 | 0.08 | 1.7K | 3,435,666 | — | ↗ |
| 2021-06-01 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 20,000 | 0.06 | 1.2K | 3,458,166 | — | ↗ |
| 2021-05-26 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 29,000 | 0.08 | 2.4K | 3,478,166 | — | ↗ |
| 2021-05-17 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 20,000 | 0.05 | 1.1K | 3,507,166 | — | ↗ |
| 2021-05-14 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 20,000 | 0.06 | 1.2K | 3,527,166 | — | ↗ |
| 2021-05-07 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 30,000 | 0.10 | 2.9K | 3,547,166 | — | ↗ |
| 2021-05-03 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 30,000 | 0.88 | 26.3K | 3,577,166 | — | ↗ |
| 2021-04-28 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 15,250 | 0.11 | 1.7K | 3,607,166 | — | ↗ |
| 2021-04-22 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 25,833 | 0.12 | 3.0K | 3,622,416 | — | ↗ |
| 2021-04-05 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 32,220 | 0.18 | 5.8K | 3,648,249 | — | ↗ |
| 2021-04-01 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 20,000 | 0.20 | 4.1K | 3,680,469 | — | ↗ |
| 2021-03-30 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 15,000 | 0.23 | 3.4K | 3,700,469 | — | ↗ |
| 2021-03-26 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 10,000 | 0.24 | 2.4K | 3,715,469 | — | ↗ |
| 2021-03-19 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 10,000 | 0.31 | 3.1K | 3,725,469 | — | ↗ |
| 2021-03-12 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 10,000 | 0.28 | 2.8K | 3,735,469 | — | ↗ |
| 2021-03-05 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 10,000 | 0.30 | 3.0K | 3,745,469 | — | ↗ |
| 2021-03-03 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 5,000 | 0.32 | 1.6K | 3,755,469 | — | ↗ |
| 2021-03-02 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 7,500 | 0.35 | 2.6K | 3,760,469 | — | ↗ |
| 2021-02-25 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 10,000 | 0.40 | 4.0K | 3,767,969 | — | ↗ |
| 2021-02-24 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 10,000 | 0.36 | 3.6K | 3,777,969 | — | ↗ |
| 2021-02-22 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 6,700 | 0.35 | 2.4K | 3,787,969 | — | ↗ |
| 2021-02-19 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 5,500 | 0.40 | 2.2K | 3,794,669 | — | ↗ |
| 2021-02-18 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 2,300 | 0.51 | 1.2K | 3,800,169 | — | ↗ |
| 2021-02-17 | Wolfson Matthew | Director / Officer / 10% Owner | A-Award | A | COMMON | 1,100,000 | 0.54 | 594.0K | 15,306,250 | — | ↗ |
| 2021-02-17 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 5,000 | 0.60 | 3.0K | 3,802,469 | — | ↗ |
| 2021-02-16 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 5,000 | 0.49 | 2.4K | 3,807,469 | — | ↗ |
| 2021-02-12 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 7,000 | 0.56 | 3.9K | 3,812,469 | — | ↗ |
| 2021-02-11 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 8,600 | 0.50 | 4.3K | 3,819,469 | — | ↗ |
| 2021-02-10 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 7,000 | 0.56 | 3.9K | 3,828,069 | — | ↗ |
| 2021-02-08 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common | 5,000 | 0.57 | 2.8K | 3,835,069 | — | ↗ |
| 2021-02-05 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 10,000 | 0.46 | 4.6K | 3,840,069 | — | ↗ |
| 2021-02-04 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common stock | 5,000 | 0.43 | 2.1K | 3,850,069 | — | ↗ |
| 2021-02-03 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common | 6,000 | 0.41 | 2.5K | 3,855,069 | — | ↗ |
| 2021-02-02 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common | 5,000 | 0.42 | 2.1K | 3,861,069 | — | ↗ |
| 2021-01-28 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common | 10,500 | 0.66 | 6.9K | 3,866,069 | — | ↗ |
| 2021-01-27 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common | 13,000 | 0.63 | 8.2K | 3,876,569 | — | ↗ |
| 2021-01-26 | STEINBERG DONALD J | 10% Owner | S-Sale | D | COMMON | 18,680 | 0.60 | 11.1K | 3,889,569 | — | ↗ |
| 2021-01-25 | STEINBERG DONALD J | 10% Owner | S-Sale | D | Common | 20,000 | 0.51 | 10.3K | 3,908,249 | — | ↗ |
| 2020-08-06 | Wolfson Matthew | Director / Officer | — | D | Common | 0 | 0.00 | — | 14,206,250 | — | ↗ |
| 2020-08-05 | STEINBERG DONALD J | 10% Owner | — | D | COMMON | 0 | 0.00 | — | 3,928,249 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-1.7K
Shares Outstanding
855.04M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Matthew N. Wolfson | Chief Executive Officer, President, Chairman, Chief Financial Officer, Treasurer & Secretary | 425.0K | male |
| Alexander A. Pedenko | Chief Medical Advisor | — | male |
| Kathy Strand | Director of Sales & Training | — | female |
| Petar Gajic | Chief Information Officer, Director of Technology & Employee Director | — | male |
| Tad Mailander | Counsel | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EMED
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
